Research suggests that bitter gourd (karela) may support liver health by reducing fat accumulation, lowering oxidative stress, and improving lipid profiles under conditions of high cholesterol, high-fat diet, or diabetes — findings reported across multiple animal studies using rats and mice. Studies indicate these effects may involve activation of fat-metabolism pathways, antioxidant activity, and modulation of inflammatory markers in liver tissue, with microscopic examination of liver cells in several studies showing reduced structural damage in treated animals compared to controls. However, the available evidence comes entirely from preclinical animal research, with no human clinical trials represented in this body of literature, and at least one study found that effects differed meaningfully by biological sex — with bitter melon producing unfavorable metabolic outcomes in female mice — while another noted that antioxidant effects may be more complex in the context of cancer or chemical exposure than in otherwise healthy animals. Additionally, safety-related findings, including reports of cytotoxicity in cell-based testing and documented cases of serious human illness linked to related cucurbit plants containing high levels of naturally occurring toxic compounds, underscore that bitter gourd preparations are not without risk and that the promising liver-related findings observed in animals have not yet been validated in human populations.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Effects of Karela (Bitter Melon; Momordica charantia) on genes of lipids and ... | Other | 2017 | Supports | 72 |
| Assessment of effects on health due to consumption of bitter bottle gourd (La... | Other | 2012 | Neutral | 67 |
| Wild bitter gourd extract up-regulates mRNA expression of PPARα, PPARγ and th... | Other | 2011 | Supports | 62 |
| Hypolipidemic and antioxidant potential of bitter gourd (Momordica charantia ... | Other | 2018 | Supports | 57 |
| Polysaccharide from Momordica charantia L. Alleviates Type 2 Diabetes Mellitu... | Other | 2025 | Supports | 52 |
| Pomegranate Seed Oil and Bitter Melon Extract Affect Fatty Acids Composition ... | Other | 2020 | Supports | 47 |
| Supplementation with Hualian No. 4 wild bitter gourd (Momordica charantia Lin... | Other | 2017 | Supports | 42 |
| Potential adverse effects of botanical supplementation in high-fat-fed female... | Other | 2018 | — | 37 |
| Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordic... | Other | 2001 | Supports | 32 |
| Pomegranate seed oil and bitter melon extract supplemented in diet influence ... | Other | 2021 | Mixed | 27 |
| Pharmacological reflection of plants traditionally used to manage diabetes me... | Review | 2021 | Neutral | 22 |
| Cytotoxicity and maternal toxicity attributed to exposure to Momordica charan... | Other | 2023 | — | 17 |